Abstract
High atherosclerosis prevalence was found in rheumatoid arthritis (RA), and the von Willebrand factor (vWF) was shown to be a marker for endothelial damage. The aim of this study was to evaluate the association of intima-media thickness of the left common carotid artery with vWF serum levels in rheumatoid arthritis patients without cardiovascular risk factors. We included 55 RA female patients, each with at least 5 years of duration of the disease, and 20 healthy female subjects as members of the control group. The vWF, cholesterol, triglycerides, and the immune variables—rheumatoid factor and reactive C protein—were evaluated. The media thickness and intima-media thickness (IMT) in patients and in the control subjects were assessed by Doppler ultrasound of the left common carotid artery. Although the ages for RA patients and healthy female controls were not different, the IMT of the left common carotid artery (IMT CCA) in rheumatoid arthritis patients was increased in comparison with healthy control measurements, the mean being 0.67 mm (SD 0.18) vs 0.58 mm (SD 0.10) with a p value 0.01. The vWF serum levels showed differences in RA patients from those in control patients, 145.6 (SD 30.08) vs 121.8 (SD 37.17), respectively, with p=0.007. A correlation was also found between vWF with IMT CCA in the RA patients: r=0.390 and p<0.05. We concluded that the measurements of the left common carotid artery intima-media thickness together with the von Willebrand factor serum levels could give valuable information about the artery status and the atherosclerosis process in early stages in patients with rheumatoid arthritis without cardiovascular risk factors.
Similar content being viewed by others
References
Wiles N, Symmons DP, Harrison B, Barret E, Barret JH, Scott DG, Silman AJ (1999) Estimating the incidence of rheumatoid arthritis: trying to hit a moving target? Arthritis Rheum 42:1339–1346
Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, Spitz PW, Kleinheksel SM, Cathey MA (1994) The mortality of rheumatoid arthritis. Arthritis Rheum 37:481–494
Pap T, Distler O (2005) Linking angiogenesis to bone destruction in arthritis. Arthritis Rheum 52:1346–1348
Taylor PC (2002) VEFG and imaging of vessels in rheumatoid arthritis. Arthritis Res 4:S99–S107
Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik JP, Cylwik B, Skowronski J, Chwiecko J (2003) Interleukin-6, soluble interleukin-2 receptor and soluble interleukin-6 receptor in the sera of patients with different histological patterns of rheumatoid synovitis. Clin Exp Rheumatol 21:63–69
Lindqvist E, Eberhardt K, Bendtzen K, Heinegard D, Saxne T (2005) Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis 64:196–201
Felmeden DC, Blann AD, Spencer CG, Beevers DG, Lip GY (2003) A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial. Blood Coagul Fibrinolysis 14:425–431
Voskuyl AE, Hazes JM, Zwinderman AH, Paleolog EM, van der Meer FJ, Daha MR et al (2003) Diagnostic strategy for the assessment of rheumatoid vasculitis. Ann Rheum Dis 62:407–413
Myllykangas-Luosujärvi R, Aho K, Kautiainen H, Isomäki H (1995) Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol 22:1065–1067
van Doornum S, Mc Coll G, Wicks IP (2002) Accelerated atherosclerosis: an extra-articular feature of rheumatoid arthritis? Arthritis Rheum 46:862–873
Gonzalez-Juanatey C, Llorca J, Testa A, Revuelta J, Garcia-Porrua C, Gonzalez-Gay MA (2003) Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine 82:407–413
Del Rincón I, Williams K, Stern M, Freeman GL, Escalante A (2001) High Incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44:2737–2745
Park YB, Ahn Ch-W, Choi H, Lee SH, In B-H, Lee H-Ch et al (2002) Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum 46:1714–1719
Del Rincon I, Williams K, Stern MP, Freeman GL, O’leary D, Escalante A (2003) Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 48:1833–1840
Jonsson SW, Backman Ch, Johnson O, Karp O, Lundströn E, Sundqvist KG, Dahlqvist SR (2001) Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol 28:2597–2602
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
Prevoo MLL, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LBA, van Riel PLCM (1995) Modified disease activity scores that include twenty-eight-joints counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48
Rosvall M, Ostergren PO, Hedblad B, Isacsson S-O, Janzon L, Berglund G (2000) Occupational status, educational level, and the prevalence of carotid atherosclerosis in a general population sample of middle-aged Swedish men and women: results from the Malmö diet and cancer study. Am J Epidemiol 152:334–346
Sramek A, Bosch J, Reiber J, van OOstayen J, Rosendaal F (2000) Ultrasound assessment of atherosclerotic vessel wall changes: Reproductibility of intima-media thickness measurements in carotid and femoral arteries. Invest Radiol 35:699–706
Roman M, Moeller E, Davis AB, Paget S, Crow M, Lockshin M et al (2006) Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med 144:249–256
Grover S, Sinha RP, Singh U, Tewari S, Aggarwal A, Misra R (2006) Subclinical atherosclerosis in Rheumatoid Arthritis in India. J Rheumatol 33:244–247
Wallberg-Jonsson S, Cvetkovic JT, Sundqvist KG, Lefvert AK, Rantapaa-Dahlqvist S (2002) Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis. J Rheumatol 29:875–882
Wallberg-Jonsson S, Cederfelt M, Rantapaa Dahlqvist S (2000) Hemostatic factors and cardiovascular disease in active rheumatoid arthritis: an 8-year follow-up study. J Rheumatol 27:71–75
McEntegart A, Capell HA, Creran D, Rumley A, Woodward M, Lowe GD (2001) Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology 40:640–644
Hoekstra M, Haagsma CJ, Doelman CJ, van der Laar MA (2005) Intermittent rises in plasma homocysteine in patients with rheumatoid arthritis treated with higher dose methotrexate. Ann Rheum Dis 64:141–143
Cisternas M, Gutierrez M, Klaassen J, Acosta A, Jacobelli S (2002) Cardiovascular risk factors in Chilean patients with rheumatoid arthritis. J Rheumatol 29:1619–1622
Ruderman EM, Crawford JM, Maier A, Liu JJ, Gravallese EM, Weinblat ME (1997) Histologic liver abnormalities in an autopsy series of patients with rheumatoid arthritis. Br J Rheumatol 36:210–213
Abraham S, Begur S, Isenberg D (2004) Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis 63:123–129
Iannello S, Cavaleri A, Milazzo P, Cantarella S, Belfiore F (2003) Low fasting serum triglyceride level as a precocious marker of autoimmune disorders. MedGenMed 5(3):20
Hanley AJ, Williams K, Festa A, Wagenknecht LE, D’Agostino RB Jr, Haffner SM (2005) Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes 54:3140–3147
Acknowledgement
This work was supported by a grant from the Instituto Mexicano del Seguro Social, No. FP-2005/6/I/438.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Daza, L., Aguirre, M., Jimenez, M. et al. Common carotid intima-media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors. Clin Rheumatol 26, 533–537 (2007). https://doi.org/10.1007/s10067-006-0338-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-006-0338-7